Short answer · Medically reviewed summary · Last updated: 2026-05-08
The primary treatment for Congenital Adrenal Hyperplasia (CAH) involves lifelong hormone replacement therapy to replace deficient cortisol and, in salt-wasting forms, mineralocorticoids. Because Congenital Adrenal Hyperplasia (CAH) manifests differently in every patient, treatment must be personalized by an endocrinologist to balance hormone levels while minimizing side effects. What are the standard medications for Congenital Adrenal Hyperplasia (CAH)? Management of Congenital Adrenal Hyperplasia (CAH) focuses on replacing missing hormones and suppressing excessive adrenal androgen production.
2 people with Congenital Adrenal Hyperplasia (CAH) have shared their first-person experience on this question at DiseaseMaps.
The primary treatment for Congenital Adrenal Hyperplasia (CAH) involves lifelong hormone replacement therapy to replace deficient cortisol and, in salt-wasting forms, mineralocorticoids. Because Congenital Adrenal Hyperplasia (CAH) manifests differently in every patient, treatment must be personalized by an endocrinologist to balance hormone levels while minimizing side effects.
Management of Congenital Adrenal Hyperplasia (CAH) focuses on replacing missing hormones and suppressing excessive adrenal androgen production. Standard pharmacological protocols typically include:
While medication is the cornerstone of care, some patients with Congenital Adrenal Hyperplasia (CAH) may require surgical intervention. Genitoplasty may be considered for individuals with atypical genital development, though current clinical guidelines emphasize shared decision-making and often advocate for deferring non-urgent procedures until the patient can participate in the decision. Psychosocial support is also a critical, non-pharmacological "treatment" to address the unique challenges of living with a chronic endocrine condition.
Effective management of Congenital Adrenal Hyperplasia (CAH) requires a multidisciplinary approach. Your care team should ideally include:
Medical research is actively exploring new therapies, such as modified-release hydrocortisone (Chronocort) and CRF1 receptor antagonists, which aim to better mimic the body's natural circadian rhythm of cortisol production. Clinical trials are ongoing to determine if these options can improve long-term outcomes for those with Congenital Adrenal Hyperplasia (CAH).
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; always consult your personal healthcare team for diagnosis and treatment decisions.